The NAB first proposed the software-based EAS option in December of 2022 and said it has developed proposals for the system ...
The U.S. Food and Drug Administration granted marketing authorization for the first home-based, nonprescription diagnostic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback